医药生物IPO“港漂”热潮:三大热门创新药成焦点,恒瑞医药4个月便实现A+H

时代周报
Jun 13, 2025

图源:图虫创意来源丨时代商业研究院作者丨陆烁宜编辑丨郑琳今年以来有个明显趋势,医药生物企业扎堆赴港IPO。时代商业研究院统计发现,今年前5个月,港股医药生物新股数量跟去年同期相比翻倍。另外,目前还有约20家医药生物企业正在排队冲击港股IPO。部分企业“弃A转港”,或为这波港股医药生物IPO热潮添一把火。另外,时代商业研究院梳理发现,无论是今年已赴港上市,还是正在冲击港股IPO的医药生物企业,大部分...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10